Laurie K Granberry, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Laurie K Granberry’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$3,269 in 2023
Medicaid paid $3,269 for 257 billed services this clinician did in 2023, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hemoglobin A1C level | 86 | $946 |
| Blood test, lipids (cholesterol and triglycerides) | 57 | $865 |
| COMPREHENSIVE METABOLIC PANEL | 59 | $707 |
| Thyroid stimulating hormone (TSH) | 26 | $495 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 29 | $256 |
| 2023 | 257 | 5 | 20 | $3,269 |
| 2022 | 530 | 17 | 28 | $22,836 |
| 2021 | 2,597 | 20 | 57 | $295,874 |
| 2020 | 443 | 3 | 50 | $40,486 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 26 | $15,844 |
| Measurement of vitamin D in serum | 61 | $1,508 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 27 | $1,080 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 26 | $1,040 |
| Blood test, lipids (cholesterol and triglycerides) | 64 | $972 |
| Hemoglobin A1C level | 68 | $748 |
| Thyroid stimulating hormone (TSH) | 29 | $552 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 52 | $459 |
| COMPREHENSIVE METABOLIC PANEL | 14 | $168 |
| ELECTROLYTE PANEL | 19 | $151 |
| Creatinine; other source | 18 | $102 |
| Albumin; urine (eg, microalbumin), quantitative | 15 | $98 |
2021
| Clinic visit/encounter, all-inclusive | 544 | $280,771 |
| Blood test, lipids (cholesterol and triglycerides) | 187 | $2,839 |
| Hemoglobin A1C level | 239 | $2,629 |
| Thyroid stimulating hormone (TSH) | 134 | $2,551 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | 38 | $1,520 |
| COMPREHENSIVE METABOLIC PANEL | 121 | $1,450 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 152 | $1,341 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | 33 | $1,320 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 12 | $480 |
| Creatinine; other source | 72 | $410 |
| Albumin; urine (eg, microalbumin), quantitative | 57 | $373 |
| ELECTROLYTE PANEL | 13 | $103 |
2020
| Clinic visit/encounter, all-inclusive | 176 | $40,486 |
| Short return visit | 62 | $0 |
| Short return visit (20+ min) | 205 | $0 |
Drugs they prescribed that Part D paid
$78,052
Pharmacies billed $78,052 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (16 of 864) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
760 generic and 104 brand-name prescriptions · $78,052 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 18 | $25,760 | $1,431 |
| Advair Hfa | 11 | $3,060 | $278 |
| Albuterol Sulfate Hfa | 22 | $706 | $32 |
| Atorvastatin | 85 | $660 | $8 |
| Metoprolol | 26 | $542 | $21 |
See all 23 drugs
| Jardiance | 18 | $25,760 | $1,431 |
| Advair Hfa | 11 | $3,060 | $278 |
| Albuterol Sulfate Hfa | 22 | $706 | $32 |
| Atorvastatin | 85 | $660 | $8 |
| Metoprolol | 26 | $542 | $21 |
| Losartan | 41 | $389 | $9 |
| Gabapentin | 20 | $316 | $16 |
| Glipizide | 17 | $245 | $14 |
| Metformin | 32 | $216 | $7 |
| Levothyroxine | 19 | $211 | $11 |
| Amlodipine Besylate | 48 | $165 | $3 |
| Simvastatin | 14 | $153 | $11 |
| Hydrochlorothiazide | 27 | $141 | $5 |
| Fluticasone Propionate | 23 | $139 | $6 |
| Tamsulosin | 18 | $137 | $8 |
| Ibuprofen | 30 | $136 | $5 |
| Baclofen | 19 | $128 | $7 |
| Atenolol | 14 | $119 | $8 |
| Lisinopril | 27 | $97 | $4 |
| Omeprazole | 20 | $73 | $4 |
| Pantoprazole | 11 | $66 | $6 |
| Triamcinolone Acetonide | 11 | $63 | $6 |
| Furosemide | 11 | $21 | $2 |
Year by year
| 2024 | 864 | 107 | 2% (16) | 12% | $78,052 |
| 2023 | 981 | 89 | 1% (12) | None | $88,795 |
| 2022 | 1,005 | 77 | 1% (14) | None | $101,706 |
| 2021 | 966 | 81 | 2% (17) | 14% | $105,193 |
| 2020 | 1,179 | 84 | 1% (16) | 17% | $123,142 |
| 2019 | 1,090 | 106 | None | 18% | $72,828 |
| 2018 | 604 | 89 | 2% (12) | 16% | $39,334 |
| 2017 | 450 | 161 | None | 21% | $38,390 |
| 2016 | 920 | 219 | None | 16% | $71,901 |
| 2015 | 770 | 181 | None | None | $62,880 |
| 2014 | 681 | 181 | None | None | $45,641 |
| 2013 | 627 | 185 | None | None | $39,720 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Jardiance | 12 | $18,241 | $1,520 |
| Atorvastatin | 97 | $2,261 | $23 |
| Losartan | 65 | $1,575 | $24 |
| Diclofenac | 30 | $1,128 | $38 |
| Albuterol Sulfate Hfa | 26 | $1,128 | $43 |
| Famotidine | 32 | $1,023 | $32 |
| Metformin | 42 | $983 | $23 |
| Amlodipine Besylate | 50 | $752 | $15 |
| Gabapentin | 12 | $738 | $62 |
| Omeprazole | 18 | $679 | $38 |
| Levothyroxine | 44 | $659 | $15 |
| Tamsulosin | 29 | $657 | $23 |
| Metoprolol | 31 | $596 | $19 |
| Clopidogrel | 24 | $563 | $23 |
| Glipizide | 17 | $525 | $31 |
| Atenolol | 11 | $393 | $36 |
| Simvastatin | 15 | $334 | $22 |
| Lisinopril | 14 | $303 | $22 |
| Isosorbide Mononitrate Er | 13 | $277 | $21 |
| Baclofen | 12 | $273 | $23 |
| Ibuprofen | 26 | $252 | $10 |
| Fluticasone Propionate | 18 | $211 | $12 |
| Risperidone | 12 | $140 | $12 |
| Prochlorperazine Maleate | 11 | $106 | $10 |
| Furosemide | 17 | $93 | $5 |
2022: 28 drugs
| Jardiance | 15 | $24,610 | $1,641 |
| Atorvastatin | 104 | $1,425 | $14 |
| Potassium Chloride | 11 | $1,091 | $99 |
| Levothyroxine | 36 | $805 | $22 |
| Metformin | 42 | $743 | $18 |
| Albuterol Sulfate Hfa | 18 | $736 | $41 |
| Glipizide | 28 | $707 | $25 |
| Famotidine | 31 | $692 | $22 |
| Diclofenac | 29 | $658 | $23 |
| Gabapentin | 15 | $597 | $40 |
| Amlodipine Besylate | 44 | $536 | $12 |
| Omeprazole | 27 | $462 | $17 |
| Metoprolol | 21 | $461 | $22 |
| Fluoxetine | 12 | $453 | $38 |
| Baclofen | 15 | $391 | $26 |
| Simvastatin | 19 | $379 | $20 |
| Isosorbide Mononitrate Er | 23 | $359 | $16 |
| Tamsulosin | 30 | $350 | $12 |
| Losartan | 22 | $350 | $16 |
| Hydralazine | 19 | $342 | $18 |
| Atenolol | 13 | $324 | $25 |
| Clopidogrel | 14 | $277 | $20 |
| Lisinopril | 21 | $214 | $10 |
| Ibuprofen | 26 | $196 | $8 |
| Carvedilol | 15 | $184 | $12 |
| Furosemide | 23 | $178 | $8 |
| Fluticasone Propionate | 17 | $160 | $9 |
| Hydroxyzine | 14 | $77 | $6 |
2021: 24 drugs
| Januvia | 21 | $32,115 | $1,529 |
| Jardiance | 16 | $20,555 | $1,285 |
| Atorvastatin | 86 | $1,598 | $19 |
| Gabapentin | 38 | $875 | $23 |
| Levothyroxine | 26 | $509 | $20 |
| Baclofen | 18 | $447 | $25 |
| Metformin | 46 | $407 | $9 |
| Metoprolol | 20 | $400 | $20 |
| Amlodipine Besylate | 43 | $397 | $9 |
| Omeprazole | 37 | $396 | $11 |
| Famotidine | 24 | $352 | $15 |
| Atenolol | 21 | $338 | $16 |
| Fosinopril | 16 | $328 | $21 |
| Losartan | 21 | $316 | $15 |
| Glipizide | 28 | $315 | $11 |
| Fluoxetine | 11 | $258 | $23 |
| Trazodone | 11 | $248 | $23 |
| Tamsulosin | 14 | $188 | $13 |
| Fluticasone Propionate | 18 | $177 | $10 |
| Lisinopril | 22 | $143 | $7 |
| Ibuprofen | 24 | $130 | $5 |
| Sertraline | 14 | $116 | $8 |
| Simvastatin | 21 | $111 | $5 |
| Tramadol | 11 | $36 | $3 |
2020: 36 drugs
| Januvia | 24 | $32,148 | $1,339 |
| Advair Diskus | 13 | $6,602 | $508 |
| Atorvastatin | 89 | $994 | $11 |
| Ventolin Hfa | 14 | $993 | $71 |
| Midodrine | 11 | $980 | $89 |
| Levothyroxine | 34 | $740 | $22 |
| Albuterol Sulfate Hfa | 15 | $702 | $47 |
| Baclofen | 28 | $580 | $21 |
| Clotrimazole | 19 | $563 | $30 |
| Gabapentin | 44 | $537 | $12 |
| Losartan | 25 | $443 | $18 |
| Metoprolol | 20 | $359 | $18 |
| Metformin | 35 | $331 | $9 |
| Duloxetine | 16 | $305 | $19 |
| Fluticasone Propionate | 20 | $261 | $13 |
| Fosinopril | 15 | $259 | $17 |
| Trazodone | 22 | $232 | $11 |
| Omeprazole | 38 | $231 | $6 |
| Famotidine | 25 | $231 | $9 |
| Amlodipine Besylate | 47 | $209 | $4 |
| Tamsulosin | 23 | $196 | $9 |
| Hydralazine | 17 | $185 | $11 |
| Isosorbide Mononitrate Er | 14 | $172 | $12 |
| Glipizide | 24 | $171 | $7 |
| Fluoxetine | 12 | $170 | $14 |
| Atenolol | 25 | $151 | $6 |
| Hydroxyzine | 16 | $150 | $9 |
| Ibuprofen | 22 | $126 | $6 |
| Simvastatin | 22 | $119 | $5 |
| Triamcinolone Acetonide | 19 | $104 | $5 |
| Lisinopril | 17 | $95 | $6 |
| Clopidogrel | 13 | $88 | $7 |
| Benazepril | 11 | $68 | $6 |
| Sertraline | 11 | $66 | $6 |
| Metoprolol | 13 | $63 | $5 |
| Hydrochlorothiazide | 12 | $34 | $3 |
2019: 28 drugs
| Advair Diskus | 13 | $6,736 | $518 |
| Ventolin Hfa | 20 | $1,577 | $79 |
| Atorvastatin | 87 | $1,307 | $15 |
| Levothyroxine | 51 | $849 | $17 |
| Metoprolol | 25 | $702 | $28 |
| Trazodone | 24 | $571 | $24 |
| Fluoxetine | 18 | $452 | $25 |
| Tamsulosin | 23 | $422 | $18 |
| Metformin | 42 | $358 | $9 |
| Famotidine | 21 | $348 | $17 |
| Fluticasone Propionate | 27 | $343 | $13 |
| Gabapentin | 18 | $318 | $18 |
| Omeprazole | 27 | $279 | $10 |
| Lisinopril | 32 | $271 | $8 |
| Amlodipine Besylate | 40 | $262 | $7 |
| Clotrimazole | 11 | $252 | $23 |
| Glipizide | 26 | $246 | $9 |
| Fosinopril | 13 | $240 | $18 |
| Losartan | 23 | $230 | $10 |
| Atenolol | 25 | $227 | $9 |
| Baclofen | 23 | $197 | $9 |
| Clopidogrel | 17 | $176 | $10 |
| Ibuprofen | 24 | $147 | $6 |
| Alendronate | 14 | $136 | $10 |
| Triamcinolone Acetonide | 13 | $121 | $9 |
| Furosemide | 16 | $107 | $7 |
| Hydroxyzine | 14 | $103 | $7 |
| Simvastatin | 13 | $65 | $5 |
2018: 15 drugs
| Ventolin Hfa | 13 | $928 | $71 |
| Atorvastatin | 38 | $536 | $14 |
| Metoprolol | 20 | $526 | $26 |
| Tamsulosin | 18 | $334 | $19 |
| Fluticasone Propionate | 23 | $303 | $13 |
| Lisinopril | 33 | $207 | $6 |
| Hydroxyzine | 18 | $191 | $11 |
| Glipizide | 24 | $161 | $7 |
| Trazodone | 11 | $152 | $14 |
| Levothyroxine | 12 | $145 | $12 |
| Omeprazole | 14 | $128 | $9 |
| Amlodipine Besylate | 17 | $118 | $7 |
| Metformin | 21 | $104 | $5 |
| Ibuprofen | 16 | $68 | $4 |
| Simvastatin | 12 | $37 | $3 |
2017: 9 drugs
| Myrbetriq | 16 | $4,506 | $282 |
| Tamsulosin | 56 | $1,301 | $23 |
| Oxybutynin Chloride Er | 19 | $827 | $44 |
| Ventolin Hfa | 14 | $682 | $49 |
| Proair Hfa | 12 | $678 | $56 |
| Finasteride | 14 | $299 | $21 |
| Cephalexin | 35 | $191 | $5 |
| Ibuprofen | 22 | $81 | $4 |
| Triamcinolone Acetonide | 11 | $77 | $7 |
2016: 16 drugs
| Myrbetriq | 48 | $16,345 | $341 |
| Elmiron | 18 | $11,943 | $664 |
| Vesicare | 15 | $8,884 | $592 |
| Oxybutynin Chloride Er | 130 | $6,539 | $50 |
| Tamsulosin | 225 | $6,460 | $29 |
| Finasteride | 106 | $1,909 | $18 |
| Dutasteride | 17 | $1,567 | $92 |
| Nitrofurantoin | 11 | $1,195 | $109 |
| Potassium Citrate Er | 12 | $1,030 | $86 |
| Doxazosin Mesylate | 22 | $932 | $42 |
| Oxybutynin Chloride | 22 | $547 | $25 |
| Cephalexin | 52 | $331 | $6 |
| Amitriptyline | 14 | $297 | $21 |
| Ciprofloxacin | 18 | $103 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $43 | $4 |
| Ibuprofen | 11 | $40 | $4 |
2015: 11 drugs
| Vesicare | 21 | $11,550 | $550 |
| Tamsulosin | 251 | $8,730 | $35 |
| Oxybutynin Chloride Er | 140 | $8,721 | $62 |
| Myrbetriq | 17 | $5,876 | $346 |
| Avodart | 11 | $5,041 | $458 |
| Premarin | 12 | $3,060 | $255 |
| Finasteride | 116 | $2,087 | $18 |
| Jalyn | 12 | $1,996 | $166 |
| Oxybutynin Chloride | 39 | $1,551 | $40 |
| Doxazosin Mesylate | 19 | $1,077 | $57 |
| Cephalexin | 29 | $170 | $6 |
2014: 11 drugs
| Vesicare | 20 | $9,352 | $468 |
| Avodart | 29 | $9,116 | $314 |
| Tamsulosin | 197 | $6,100 | $31 |
| Oxybutynin Chloride Er | 90 | $5,238 | $58 |
| Oxybutynin Chloride | 50 | $2,263 | $45 |
| Doxazosin Mesylate | 30 | $1,635 | $55 |
| Finasteride | 58 | $1,374 | $24 |
| Ciprofloxacin | 34 | $238 | $7 |
| Sodium Chloride | 26 | $173 | $7 |
| Cephalexin | 25 | $158 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $93 | $5 |
2013: 14 drugs
| Avodart | 29 | $8,441 | $291 |
| Vesicare | 19 | $5,796 | $305 |
| Tamsulosin | 160 | $4,417 | $28 |
| Oxybutynin Chloride Er | 49 | $4,035 | $82 |
| Premarin | 14 | $2,595 | $185 |
| Finasteride | 43 | $2,159 | $50 |
| Oxybutynin Chloride | 82 | $1,723 | $21 |
| Nitrofurantoin | 13 | $1,081 | $83 |
| Doxazosin Mesylate | 29 | $910 | $31 |
| Nitrofurantoin Mono-Macro | 11 | $417 | $38 |
| Sodium Chloride | 28 | $166 | $6 |
| Ciprofloxacin | 20 | $137 | $7 |
| Sulfamethoxazole-Trimethoprim | 17 | $102 | $6 |
| Cephalexin | 12 | $101 | $8 |
Money from drug and device companies
$137 in 2025
| 2025 | 1 | 1 | None | $137 |
| 2024 | 1 | 1 | None | $122 |
| 2023 | 3 | 3 | None | $340 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $137 | 1 payment
|
See the published payment
| Edwards Lifesciences | Meals · 2025-03-28 | Sapien 3 Ultra Resilia | $137 |
See earlier years (2024, 2023)
2024: $122
| Averitas Pharma | Qutenza | $122 | 1 payment
|
2023: $340
| Mayne Pharma Commercial | Nextstellis | $124 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $122 | 1 payment
|
| Biogen | None | $94 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699832725
- Licence
- CA NP16621
- Trained
- University of California, San Francisco School of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-01-01
- NPI last updated
- 2012-08-29
This is when the NPI record was last certified, not a medical board exam.